Maria Cherska: Lipid Metabolism and Immune Remodeling in Metastatic Colorectal Cancer
Maria Cherska, The Head of Cardiology Department at The State Institution V.P. Komisarenko Institute of Endocrinology and Metabolism, shared a post on LinkedIn about a recent article by Yuru Shang et al., published in Lipids in Health and Desease, adding:
“Lipid metabolism is emerging as a new frontier in cancer research.
A new review in Lipids in Health and Disease highlights how lipid metabolic reprogramming can reshape the immune microenvironment in metastatic colorectal cancer—affecting T-cell exhaustion, immune escape, ferroptosis, and therapeutic response.
Key pathways include FASN, CD36, HMGCR, PCSK9, and SREBP, opening intriguing possibilities for combining metabolic targeting with immunotherapy.
From cardiovascular biology to precision oncology — lipids matter.”
Title: Lipid metabolism as a central driver of immune remodeling and therapeutic vulnerability in metastatic colorectal cancer
Authors: Yuru Shang, Qingxi Yang, Runlin Zhang, Weiguo Xu, A. M. Abd El-Aty, Yu Gao and Tianbao Wang
Other posts featuring Maria Cherska on Hemostasis Today.
-
Oct 18, 2026, 15:43André Marcel Harris: Award-Winning Research on Texas Sickle Cell Data Collection
-
Oct 18, 2026, 15:21Eleonora Gambineri: First Results of the IEI-Haem Consortium at ESID 2026
-
Oct 18, 2026, 15:17Alexey Kulikov: Could Platelets Reveal Frailty Before Physical Signs Appear?
-
Oct 18, 2026, 15:06Elisa Rossi: Advancing HHT Research at the 16th International Conference
-
Oct 18, 2026, 14:58Aishwarya Dash: Simplifying Bone Marrow Mesenchymal Stromal Cell Isolation
-
Oct 18, 2026, 14:54Caitlin Raymond: Could the Apheresis Circuit Itself Modulate Immunity?
-
Oct 18, 2026, 13:0810 Posts Not to Miss This Week
-
Oct 18, 2026, 12:58Pierpaolo Di Micco: DOACs vs Vitamin K Antagonists in Long-Term Anticoagulation
-
Oct 18, 2026, 12:51Arianne Missimer: Understanding Ferritin Levels Beyond the Normal Range